Our customized assay development services include a full range of assays and technologies adapted to clients specific needs. Whether performing a million-compound primary screening, or secondary profiling, you need tools that accurately predict human biology. Eurofins Pharma Discovery Services has an impressive and integrated suite of core competencies that will bring value to your drug discovery programs. A key driver of success in the drug discovery process is predicting the in vivo biological behavior of new chemical entities using customized in vitro pharmacology and ADME-Tox assays. Custom assays can be developed based on either Eurofins' or a client's own technology and using a either Eurofins' in-house produced materials, a client's materials or commercially available materials.